Volume 17, Issue 6, Pages (November 2016)

Slides:



Advertisements
Similar presentations
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
Advertisements

The Structure of a Bcl-xL/Bim Fragment Complex
Volume 8, Issue 12, Pages (December 2000)
Peter D. Kwong, John R. Mascola  Immunity 
Volume 43, Issue 5, Pages (November 2015)
Volume 23, Issue 6, Pages (May 2018)
Volume 105, Issue 4, Pages (May 2001)
Volume 22, Issue 2, Pages (February 2014)
Tsan Xiao, Par Towb, Steven A. Wasserman, Stephen R. Sprang  Cell 
Volume 35, Issue 2, Pages (July 2002)
Kristopher Josephson, Naomi J. Logsdon, Mark R. Walter  Immunity 
Structure of an LDLR-RAP Complex Reveals a General Mode for Ligand Recognition by Lipoprotein Receptors  Carl Fisher, Natalia Beglova, Stephen C. Blacklow 
Autoreactivity in Human IgG+ Memory B Cells
Volume 23, Issue 11, Pages (June 2018)
R. Elliot Murphy, Alexandra B. Samal, Jiri Vlach, Jamil S. Saad 
Volume 16, Issue 5, Pages (August 2016)
Volume 18, Issue 12, Pages (December 2010)
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
by Joseph G. Jardine, Daniel W
Structure of RGS4 Bound to AlF4−-Activated Giα1: Stabilization of the Transition State for GTP Hydrolysis  John J.G. Tesmer, David M. Berman, Alfred G.
Tamas Yelland, Snezana Djordjevic  Structure 
Volume 19, Issue 9, Pages (September 2011)
Volume 18, Issue 6, Pages (December 2015)
Volume 36, Issue 4, Pages (November 2009)
Volume 24, Issue 10, Pages e4 (September 2018)
Volume 43, Issue 6, Pages (December 2015)
Crystal Structures of Oligomeric Forms of the IP-10/CXCL10 Chemokine
Solution Structure of the Core NFATC1/DNA Complex
by Devin Sok, Bryan Briney, Joseph G. Jardine, Daniel W
Crystal Structures of RNase H Bound to an RNA/DNA Hybrid: Substrate Specificity and Metal-Dependent Catalysis  Marcin Nowotny, Sergei A. Gaidamakov, Robert.
Volume 13, Issue 12, Pages (December 2015)
Structural Insights into the Inhibition of Wnt Signaling by Cancer Antigen 5T4/Wnt- Activated Inhibitory Factor 1  Yuguang Zhao, Tomas Malinauskas, Karl.
Volume 20, Issue 1, Pages 9-19 (October 2005)
Adam S. Dingens, Hugh K. Haddox, Julie Overbaugh, Jesse D. Bloom 
Volume 20, Issue 12, Pages (September 2017)
Autoreactivity in Human IgG+ Memory B Cells
Volume 18, Issue 8, Pages (August 2010)
Error-Prone DNA Polymerases
Shaun K. Olsen, Christopher D. Lima  Molecular Cell 
Volume 21, Issue 10, Pages (December 2017)
André Schiefner, Michaela Gebauer, Antonia Richter, Arne Skerra 
Volume 23, Issue 6, Pages (May 2018)
Structural Basis of EZH2 Recognition by EED
Volume 23, Issue 3, Pages (April 2018)
Volume 25, Issue 11, Pages e4 (November 2017)
Volume 91, Issue 5, Pages (November 1997)
Volume 153, Issue 1, Pages (March 2013)
Volume 101, Issue 4, Pages (May 2000)
Crystal Structure of a Phosphoinositide Phosphatase, MTMR2
Structural Basis for FGF Receptor Dimerization and Activation
Volume 13, Issue 3, Pages (February 2004)
Meigang Gu, Kanagalaghatta R. Rajashankar, Christopher D. Lima 
Volume 15, Issue 6, Pages (December 2001)
Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10  Adriana Irimia, Anita Sarkar,
Volume 14, Issue 4, Pages (April 2006)
Volume 52, Issue 3, Pages (November 2013)
Volume 26, Issue 1, Pages (April 2007)
Volume 12, Issue 1, Pages (July 2015)
Volume 20, Issue 7, Pages (August 2017)
Volume 24, Issue 8, Pages (August 2016)
Solution Structure of a TBP–TAFII230 Complex
Volume 7, Issue 3, Pages (May 2014)
Crystal Structure of a Polymeric Immunoglobulin Binding Fragment of the Human Polymeric Immunoglobulin Receptor  Agnes E. Hamburger, Anthony P. West,
Structure of CD94 Reveals a Novel C-Type Lectin Fold
Volume 25, Issue 6, Pages e5 (June 2019)
Calibrated Measurement of Gating-Charge Arginine Displacement in the KvAP Voltage- Dependent K+ Channel  Vanessa Ruta, Jiayun Chen, Roderick MacKinnon 
Rachelle Gaudet, Andrew Bohm, Paul B Sigler  Cell 
Volume 8, Issue 10, Pages (October 2000)
Volume 49, Issue 6, Pages e8 (December 2018)
Volume 95, Issue 2, Pages (October 1998)
Presentation transcript:

Volume 17, Issue 6, Pages 1560-1570 (November 2016) Differences in Allelic Frequency and CDRH3 Region Limit the Engagement of HIV Env Immunogens by Putative VRC01 Neutralizing Antibody Precursors  Christina Yacoob, Marie Pancera, Vladimir Vigdorovich, Brian G. Oliver, Jolene A. Glenn, Junli Feng, D. Noah Sather, Andrew T. McGuire, Leonidas Stamatatos  Cell Reports  Volume 17, Issue 6, Pages 1560-1570 (November 2016) DOI: 10.1016/j.celrep.2016.10.017 Copyright © 2016 The Author(s) Terms and Conditions

Cell Reports 2016 17, 1560-1570DOI: (10.1016/j.celrep.2016.10.017) Copyright © 2016 The Author(s) Terms and Conditions

Figure 1 Relative Frequencies of VH1-2∗02-Expressing IgM+ B Cells in HIV-1− Humans Next generation deep-sequencing (MiSeq) was used to identify unique HC sequences of circulating IgM+ B cells. (A) Percentages of VH1-2 and VH1-2∗02 sequences from each of the nine donors examined are shown. The numbers represent the percent of VH1-2 sequences out of the total VH1 sequences per donor (left column) or the percentage of VH1-2 sequences derived from the ∗02 allele (right column). (–) indicates that VH1-2∗02 sequences were not detected. The data are representative from multiple (2–4) sequencing library runs from each subject. The data shown are representative of these replicate experiments. (B) The amino acid identity of the VH1-2 HC sequences from all donors examined was compared to the published germline sequences for each of the five VH1-2 alleles. The average and the median percent identity of all VH1-2 sequences from all donors are shown. (C) Distribution of CDRH3 amino acid lengths (percent of total HCs per donor) and percent of all CDRH3 sequences expressing Trp100BHC (irrespective of CDRH3 length) for each donor are shown. Cell Reports 2016 17, 1560-1570DOI: (10.1016/j.celrep.2016.10.017) Copyright © 2016 The Author(s) Terms and Conditions

Figure 2 Binding of Expressed Germline Antibodies Derived from All Five VH1-2 Alleles to the 426c degly-3 Core gp120 The complete amino acid sequences of each HC expressed as IgG are shown in Figure S3. Each antibody was tested for binding to the 426c degly-3 gp120 core: (A) monomeric form, (B) Ferritin particles (24-mer), and (C) C4b particles (7-mer). The igl VRC01 IgG was included. Binding and non-binding antibodies are indicated. For clarity, the absence of interaction of antibodies derived from alleles ∗01 and ∗05 are shown separately (D). Vertical dotted lines represent the start of the dissociation phase. Cell Reports 2016 17, 1560-1570DOI: (10.1016/j.celrep.2016.10.017) Copyright © 2016 The Author(s) Terms and Conditions

Figure 3 The Role of the CDRH3 Sequence on the Binding of Germline 02-CB Antibody to Env (A) The CDRH3 sequences of iglVRC01 and 02-CB antibodies, as well as the reverting mutations (highlighted in orange) introduced in the 02-CB CDRH3 region are shown. Trp100BHC is highlighted in yellow. Residues that make direct contact with Env are indicated by asterisks. (B and C) Binding to the C4b particles (7-mer) (B) and Ferritin particles (24-mer) (C) expressing 426c degly-3 core gp120. Vertical dotted lines indicate the start of the dissociation phases. Cell Reports 2016 17, 1560-1570DOI: (10.1016/j.celrep.2016.10.017) Copyright © 2016 The Author(s) Terms and Conditions

Figure 4 The Role of the CDRH3 Sequence on the Binding of Germline 02-J Antibody to Env (A) The CDRH3 sequences of iglVRC01, 02-J, and 02-K antibodies. The reverting mutations are highlighted in orange and Trp100BHC is highlighted in yellow. (B and C) Binding to C4b particles (7-mer) (B) and Ferritin particles (24-mer) (C) expressing 426c degly-3 core gp120 are shown. Vertical dotted lines indicate the start of the dissociation phases. Cell Reports 2016 17, 1560-1570DOI: (10.1016/j.celrep.2016.10.017) Copyright © 2016 The Author(s) Terms and Conditions

Figure 5 The Role of the CDRH2 Sequence on the Binding of Germline 02-CC Antibody to Env (A) The CDRH2 (top) and CDRH3 (bottom) sequences of iglVRC01, 02-CC, and 02-CB antibodies are shown. The reverting mutations in the CDRH2 region of 02-CC at position 54 and 56 are highlighted in orange. Trp100BHC is highlighted in yellow. (B and C) Binding to C4b particles (7-mer) (B) and Ferritin particles (24-mer) (C) expressing 426c degly-3 core gp120 are shown. Vertical dotted lines indicate the start of the dissociation phases. Cell Reports 2016 17, 1560-1570DOI: (10.1016/j.celrep.2016.10.017) Copyright © 2016 The Author(s) Terms and Conditions

Figure 6 Structural Analysis of CDRH3 of Germline VRC01-Class Antibodies (A) CDRH3 sequence alignment from matured VRC01 (muVRC01), chimeric antibodies 02-CB, 02-K, 02-CC, and recently isolated germline VRC01c-HuGL2 (Jardine et al., 2016). The residues that are known to interact with gp120 from previously-reported crystal structures (Jardine et al., 2013, 2016; Zhou et al., 2010) are shown in red, while the residues that interact with gp120 based on modeling analysis performed here are underlined. (B) Structures of unbound germline VRC01-class Fabs. Structures of each single chain variable fragment (Fv) are shown in ribbon representation with the CDRH3 residues shown in “sticks.” The superposition of five Fabs is shown on the far left panel. (C) Structures of germline VRC01-class antibodies bound to eOD-GT6 or eOD-GT8 (in the case of VRC01c-HuGL2). Superposition of the bound antibodies is shown in the far left panel. Ribbon representations of each germline antibody bound to eOD are shown separately with the residues in CDRH3 shown as sticks and residues that interact with gp120 are labeled. The structures of 02-CB, 02-K, and 02-CC antibodies bound to eOD are modeled (shown in lighter shade of gray). (D) Summary of residues in the CDRH3 of the germline antibodies that interact with gp120. Buried surface area (BSA) over 5 A2, and hydrogen bonds (H) or salt bridges (S) are indicated. Analysis for modeled interactions is italicized. Cell Reports 2016 17, 1560-1570DOI: (10.1016/j.celrep.2016.10.017) Copyright © 2016 The Author(s) Terms and Conditions